That is my understanding, on at least part of it, the part where MVTG is being paid cash for doing R&D in the MVTG lab with the 6 Ph.D.s working now in the MVTG lab. What else would the accountants call it? The inkind contributions of engineering work for the Pilot Plant is a question mark as to how the Auditors will account for it. Since it is a contribution to the construction of a pilot plant asset that MVTG will own for doing on the road demos, I would call it revenue and list it as part of the capital construction asset cost, then depreciate the asset once it is turned on, but I see so mucg screwy nonse in public accounting with the Sarbanes-Oxley accounting changes where a drop in stock price shows a gain in asset value as it eats away at a warrant value to show fake income, who knows what it will look like.
To me the three International issued patents MVTG has now should have a book value based on cost or market value listed in the financials, but the auditor is not putting any value on the MVTG patents that I suspect already have a real value of ten times the MVTG market cap.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.